Brokerages Set UnitedHealth Group Incorporated (NYSE:UNH) PT at $629.32

UnitedHealth Group Incorporated (NYSE:UNH) has received an average rating of “Buy” from the twenty-one brokerages that are presently covering the stock, MarketBeat reports. Nineteen equities research analysts have rated the stock with a buy recommendation and two have given a strong buy recommendation to the company. The average twelve-month price objective among brokerages that have covered the stock in the last year is $629.32.

UNH has been the subject of several research reports. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research note on Tuesday, December 3rd. HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price for the company in a research note on Friday, January 10th. Hsbc Global Res upgraded shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. Truist Financial decreased their target price on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Finally, Barclays decreased their target price on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research note on Friday, January 17th.

UnitedHealth Group Stock Down 0.1 %

NYSE:UNH opened at $503.05 on Monday. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group has a twelve month low of $436.38 and a twelve month high of $630.73. The company’s 50 day moving average is $510.48 and its two-hundred day moving average is $548.22. The company has a market cap of $460.14 billion, a PE ratio of 32.45, a P/E/G ratio of 1.37 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. During the same period in the previous year, the business posted $5.83 EPS. The business’s quarterly revenue was up 6.8% compared to the same quarter last year. Analysts anticipate that UnitedHealth Group will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.67%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s payout ratio is 54.19%.

Insider Transactions at UnitedHealth Group

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of the company’s stock in a transaction that occurred on Friday, January 17th. The stock was purchased at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now owns 4,500 shares of the company’s stock, valued at $2,302,065. This trade represents a 28.57 % increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Insiders own 0.33% of the company’s stock.

Institutional Investors Weigh In On UnitedHealth Group

A number of hedge funds have recently modified their holdings of the company. M&T Bank Corp boosted its stake in UnitedHealth Group by 13.4% during the third quarter. M&T Bank Corp now owns 220,590 shares of the healthcare conglomerate’s stock worth $128,975,000 after buying an additional 26,074 shares during the period. Sugarloaf Wealth Management LLC boosted its stake in UnitedHealth Group by 17.6% during the fourth quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate’s stock worth $4,025,000 after buying an additional 1,193 shares during the period. Benjamin Edwards Inc. boosted its stake in UnitedHealth Group by 1,275.3% during the third quarter. Benjamin Edwards Inc. now owns 44,547 shares of the healthcare conglomerate’s stock worth $26,060,000 after buying an additional 41,308 shares during the period. Parsifal Capital Management LP purchased a new position in UnitedHealth Group during the third quarter worth about $21,165,000. Finally, Signal Advisors Wealth LLC boosted its stake in UnitedHealth Group by 13.0% during the fourth quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate’s stock worth $4,611,000 after buying an additional 1,051 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.